What is the ROCE (Return on Capital Employed) of Innoviva this year?
The ROCE of Innoviva is 0.17 undefined this year.
Innoviva ROCE 2024
Innoviva ROCE
0.17
Ticker
INVA
ISIN
US45781M1018
WKN
A2AC9U
In 2024, Innoviva's return on capital employed (ROCE) was 0.17, a -53.88% increase from the 0.37 ROCE in the previous year.
Innoviva Aktienanalyse
What does Innoviva do?
Innoviva Inc - An innovative story Innoviva Inc is a US-based company specializing in the development and marketing of therapy and diagnostic products for respiratory diseases. The company was founded in 1996 under the name Theravance Inc and was renamed Innoviva Inc in 2016. The story of Innoviva Inc began with the goal of developing innovative therapies for chronic respiratory diseases. Over the years, the company expanded and diversified its product portfolio. Today, Innoviva Inc is a leading provider of products for the treatment of asthma and chronic obstructive pulmonary disease (COPD). Business model of Innoviva Inc The business model of Innoviva Inc is based on the development of products for the treatment of respiratory diseases and collaboration with other pharmaceutical and biotech companies. The company licenses its products to partner companies, which distribute them in the market. This way, Innoviva Inc generates revenue from licensing fees and milestone payments. Divisions of Innoviva Inc Innoviva Inc is divided into three divisions: development, licensing, and financing. The development division is responsible for researching and developing new therapy and diagnostic products. The company works closely with other pharmaceutical and biotech companies in this regard. The licensing division is responsible for licensing products to partner companies. This includes negotiating license agreements and conducting clinical trials. The financing division of Innoviva Inc is responsible for raising external capital. This includes issuing bonds and seeking investment. Products of Innoviva Inc Innoviva Inc has a wide range of therapy and diagnostic products for respiratory diseases. These include: - RELVAR®/BREO® (Fluticasone furoate/Vilanterol) for the treatment of COPD and asthma - ANORO® (Umeclidinium bromide/Vilanterol) for the treatment of COPD - TRELEGY® (Fluticasone furoate/Umeclidinium bromide/Vilanterol) for the treatment of COPD These products have been developed by Innoviva Inc and are licensed to partner companies for distribution. Innoviva Inc is an innovative company specializing in the development and marketing of products for the treatment of respiratory diseases. The business model is based on the development of products and licensing them to partner companies. Innoviva Inc has a wide range of therapy and diagnostic products for respiratory diseases. Innoviva ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROCE Details
Unraveling Innoviva's Return on Capital Employed (ROCE)
Innoviva's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.
Year-to-Year Comparison
Analyzing Innoviva's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.
Impact on Investments
Innoviva's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.
Interpreting ROCE Fluctuations
Changes in Innoviva’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.
Frequently Asked Questions about Innoviva stock
How has the ROCE (Return on Capital Employed) of Innoviva developed compared to the previous year?
The ROCE of Innoviva has increased by -53.88% decreased compared to the previous year.
What does a high ROCE (Return on Capital Employed) mean for investors of Innoviva?
A high Return on Capital Employed (ROCE) indicates that Innoviva has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.
What does a low ROCE (Return on Capital Employed) mean for investors of Innoviva?
A low ROCE (Return on Capital Employed) can indicate that Innoviva has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.
How does an increase in ROCE from Innoviva impact the company?
An increase in the ROCE of Innoviva can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.
How does a reduction in the ROCE of Innoviva affect the company?
A decrease in ROCE of Innoviva can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.
What are some factors that can influence the ROCE of Innoviva?
Some factors that can affect Innoviva's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.
Why is the ROCE of Innoviva so important for investors?
The ROCE of Innoviva is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.
What strategic measures can Innoviva take to improve the ROCE?
To improve the ROCE, Innoviva can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.
How much dividend does Innoviva pay?
Over the past 12 months, Innoviva paid a dividend of 0.75 USD . This corresponds to a dividend yield of about 3.79 %. For the coming 12 months, Innoviva is expected to pay a dividend of 0 USD.
What is the dividend yield of Innoviva?
The current dividend yield of Innoviva is 3.79 %.
When does Innoviva pay dividends?
Innoviva pays a quarterly dividend. This is distributed in the months of December, April, July, October.
How secure is the dividend of Innoviva?
Innoviva paid dividends every year for the past 0 years.
What is the dividend of Innoviva?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Innoviva located?
Innoviva is assigned to the 'Health' sector.
Wann musste ich die Aktien von Innoviva kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Innoviva from 9/30/2015 amounting to 0.25 USD, you needed to have the stock in your portfolio before the ex-date on 9/8/2015.
When did Innoviva pay the last dividend?
The last dividend was paid out on 9/30/2015.
What was the dividend of Innoviva in the year 2023?
In the year 2023, Innoviva distributed 0 USD as dividends.
In which currency does Innoviva pay out the dividend?
The dividends of Innoviva are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Innoviva stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Innoviva
Our stock analysis for Innoviva Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Innoviva Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
